NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE

Your AI-Trained Oncology Knowledge Connection!

This roundtable series considers testing for patients with HER2-negative, early-stage breast cancer, as discussed by key opinion leaders at virtual live events and interviews.

Multigene Expression Testing in Early-Stage Breast Cancer Management

Considering How TAILORx Transformed Node-Negative Breast Cancer Treatment

Considering How TAILORx Transformed Node-Negative Breast Cancer Treatment

During a live event, Heather L. McArthur, MD, MPH, discussed the TAILORx trial in node-negative hormone receptor–positive/HER2-negative breast cancer.

Exploring Genomic Assays for Early-Stage Breast Cancer Treatment

Exploring Genomic Assays for Early-Stage Breast Cancer Treatment

During a live event, Heather L. McArthur, MD, MPH, reviewed genomic assays for early-stage breast cancer.

More Options Needed for Underrepresented Patients With Breast Cancer

More Options Needed for Underrepresented Patients With Breast Cancer

Fengting Yan, MD, PhD, discusses unmet needs in breast cancer care and issues for specific subgroups of patients.

Acknowledging the Importance of Clinical Judgment in Breast Cancer

Acknowledging the Importance of Clinical Judgment in Breast Cancer

Fengting Yan, MD, PhD, discusses the challenge of balancing clinical judgment with genomic test results in breast cancer.

Oncotype DX Used for Patients With Breast Cancer to Guide Therapy

Oncotype DX Used for Patients With Breast Cancer to Guide Therapy

Fengting Yan, MD, PhD, discusses how her clinical practice is informed by data and guidelines available on testing in breast cancer.

© 2025 MJH Life Sciences^®

All rights reserved.